Explore more publications!

Press Releases

Valneva Reports Full Year 2025 Audited Consolidated Financial Results
Writer Christa Couture hits the road for more immersive, accessible Canadian adventures on Season 7 of Postcards From, returning April 29 to AMI-tv and AMI+
Valneva Reports Nine-Month 2025 Financial Results and Provides Corporate Updates
GBSA connects Pangyo’s innovative companies with global media outlets through the 2025 Pangyo Global Media Meet-Up
EU Balance of Payments and International Investment Position statistical sources and methods - B.o.p. and i.i.p. e-book

EU Balance of Payments and International Investment Position statistical sources and methods - B.o.p. and i.i.p. e-book

Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates
SCOR: Combined Shareholders’ Meeting of Tuesday 28 April 2026 – Availability of Preparatory Documents
St. Louis’ Todd Mosby and an All-Star Lineup Capture Missouri’s Soul on Powerful New Album: American Heartland
Availability of the 2025 Universal Registration Document, terms for holding the Combined General Meeting of Unibail-Rodamco-Westfield SE on May 6, 2026, and availability of the explanatory documentation
Hypersanté Hosts First Francophone Summit on Longevity and Biohacking in Paris
Pakistan Leads 2025 Global Pollution Rankings

Pakistan Leads 2025 Global Pollution Rankings

Valneva Provides Update on Recommendations for Use of IXCHIQ® in the United Kingdom
Immigration Attorney Alicia Vial Beesley of Vida Legal Services Recently Featured on Close Up Radio
Boulevard Kitchen & Oyster Bar Joins Vancouver World Chef Exchange: Bangkok × Vancouver
TGR Foundation Celebrates 20 Years of Impact Through Education at TGR Learning Lab in Anaheim
Hypersante Introduces the 2026 Longevity and Biohacking Summit in Paris
OSE Immunotherapeutics Board Urges Support for Value-Driving Strategy and Open-Minded Governance -  Publication of Circular for Combined Annual General Meeting of  September 30, 2025
Bloomin' Blinds of BuxMont Is 2025 Franchise Owner of the Year at National Awards Event
Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S.
Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions